Holen Sie sich die Stockscreener-App
0.0005
28.57%
-0.0002
Paxmedica Inc Aktie (PXMD) Neueste Nachrichten
Strategic Execution in Focus for Paxmedica Investors - AD HOC NEWS
ProMetic Life Sciences (OTCMKTS:PFSCF) & PaxMedica (NASDAQ:PXMD) Financial Contrast - Defense World
Comparing PaxMedica (NASDAQ:PXMD) & ProMetic Life Sciences (OTCMKTS:PFSCF) - Defense World
Paxmedica’s PAX-101 Under the Microscope: Pipeline Progress and FDA Milestones - AD HOC NEWS
MorphoSys (NASDAQ:MOR) vs. PaxMedica (NASDAQ:PXMD) Head to Head Comparison - Defense World
Autism Spectrum Disorder Market to Reach USD 4.07 Billion - GlobeNewswire
PXMD Stock Institutional Owners - Quiver Quantitative
Plus Therapeutics Regains Compliance With Two Nasdaq Listing Rules - marketscreener.com
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
PaxMedica Renames to Kuvatris, Cancels Shares - TipRanks
PaxMedica announces board resignations amid transition - Investing.com
PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data - ACCESS Newswire
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - ACCESS Newswire
Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc. - ACCESS Newswire
PaxMedica Secures Groundbreaking China Patent for Autism Treatment Breakthrough After 100 Years - Stock Titan
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - Yahoo Finance
Autism Spectrum Disorder Therapeutics Market size is set to grow by USD 766.1 million from 2024-2028, Increasing prevalence of asd to boost the market growth, Technavio - PR Newswire
PaxMedica (PXMD) Stock Trends and Sentiment 2025 - MarketBeat
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Yahoo Finance
Cardio Diagnostics Holdings, Inc. (CDIO) stock price, news, quote and history - Yahoo! Finance Singapore
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy - Yahoo Finance
PXMD Stock Price and Chart — OTC:PXMD - TradingView
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast - GlobeNewswire
As Autism Cases Rise, Biopharma Springs Into Action - BioSpace
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Yahoo Finance
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies By Benzinga - Investing.com UK
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - Yahoo Finance
PaxMedica, Inc. (PXMD) stock price, news, quote and history - Yahoo Finance UK
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments - GlobeNewswire
PaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASD - The Globe and Mail
Ocean Biomedical, Inc. (OCEA) options chain - Yahoo! Finance Singapore
HC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy Recommendation - Nasdaq
PaxMedica (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M - The Globe and Mail
PaxMedica prices stock and warrant offering at $1.30 per unit - Investing.com UK
PaxMedica, Inc. (PXMD) latest stock news and headlines - Yahoo Finance UK
PaxMedica News of FDA Type-B Meeting Shared in Audio Broadcast - Yahoo Finance
Why Is PaxMedica (PXMD) Stock Down 40% Today? - TradingView — Track All Markets
Virax Biolabs Group Limited (VRAX) stock price, news, quote and history - Yahoo! Finance Singapore
PaxMedica progresses with PAX-101 for sleeping sickness By Investing.com - Investing.com UK
PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcast - GlobeNewswire
PaxMedica Surges After Publication Of Statistically Significant Data From Its Autism Spectrum Study - Nasdaq
PaxMedica Acquires Suramin Research Assets from Rediscovery - GlobeNewswire
PaxMedica Announces 1-for-17 Reverse Stock Split - Yahoo Finance
PaxMedica (NASDAQ: PXMD) Reports on Low-Dose Suramin for ASD Research - Digital Journal
PaxMedica stock soars 110% on FDA update for lead drug PAX-101 (PXMD) - Seeking Alpha
The Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz Woods of PaxMedica, Inc. (Nasdaq: PXMD) - GlobeNewswire
PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023 - Yahoo Finance
PaxMedica Comments on Common Stock Volatility - Yahoo Finance
PaxMedica CEO Interviewed by The BRAIN Foundation - GlobeNewswire
PaxMedica seeks SAHPRA approval to initiate ASD therapy trial - Clinical Trials Arena
PaxMedica Submits Clinical Trial Request in Autism Spectrum Disorder - GlobeNewswire
PaxMedica and PoloMar to investigate emodin in ASD trial - Clinical Trials Arena
PaxMedica Enters Research Collaboration Agreement With - GlobeNewswire
PaxMedica Completes HAT-301 Registrational Trial for PAX-101 - GlobeNewswire
PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023 - Yahoo Finance
PaxMedica, Inc. Provides Business Update and Reports Fourth Quarter 2022 Financial Results - Yahoo Finance
PaxMedica Holds Meeting of Scientific Advisory Board - GlobeNewswire
Autistic Disorder Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight - Yahoo Finance
PaxMedica Releases 2022 Shareholder Letter - GlobeNewswire
PaxMedica Awaits HAT Trial Data - RTTNews
Top 5 most-shorted stocks as of January 2023 - Finbold
Pre-market Movers: FUV, CYAD, ATXI, CSSE, PXMD… - Nasdaq
PaxMedica, Inc. (PXMD) Latest Stock News & Headlines - Yahoo! Finance Canada
Fintel’s Top 10 Short Squeeze Score Stocks For November - Nasdaq
PaxMedica Soars on Equity Deal with Lincoln Park Capital - TipRanks
PaxMedica (PXMD) Insider Trading Activity 2025 - MarketBeat
PaxMedica Appoints Stefan Schwabe MD, PhD as Chief Medical Officer - GlobeNewswire
Best Penny Stocks To Buy Now? 4 Low Float Stocks To Watch This Week - PennyStocks.com
PaxMedica, Inc. Provides Corporate Update After IPO - GlobeNewswire
PaxMedica (PXMD) Stock Price, News & Analysis - MarketBeat
Check out Kuvatris Therapeutics's stock price (PXMD) in real time - CNBC
1.70%
0.66%
Kapitalisierung:
|
Volumen (24h):